Emil Kendziorra, the co-founder and CEO of cryonics provider Tomorrow Biostasis, presents report on quality of Tomorrow Bio's cryopreservation cases done in 2025.

Some important highlights:

• why public quality reports matter
• the mindset about handling issues during cryopreservation
• quality of cases in USA in particular
• recalibration on CT scanes based on pig tests
• electron microscopy quality tests of vitrified brain tissue (more in a dedicated webinar)
• big change on 18th February 2026
• Q&A